CD8A and neoplasm: Notably, by inhibiting the glycolytic pathway, the level of H3K18 lactylation could be reduced, thereby enhancing the cytotoxicity of CD8+ T cells and effectively inhibiting tumor growth (Zhang et al., 2024a).